San Francisco, 05 May 2025: The Report Wearable Patch Market Size, Share, & Trends Analysis Report By Type (Temperature, Glucose), By Technology (Regular, Connected), By Application (Clinical, Non-clinical), By End Use, By Region, And Segment Forecasts, 2025 - 2030

The global wearable patch market size is valued at USD 15.71 billion in 2030 and is projected to grow at a CAGR of 8.1% from 2025 to 2030. Wearable Patch is attached to the skin and can be worn for a couple of hours to weeks. In recent years these patches have become more popular and are most widely used for drug delivery or patient monitoring, and sports. They are also used to deliver medication such as nicotine and to treat various chronic diseases. Various companies are investing in this technology to gain a competitive advantage.

The connected wearable patch segment accounted for the highest market share in 2024. It has wireless connectivity features that help in monitoring the health of patients and delivering drugs accordingly. The factors responsible for the growth of the segment are growing concern among people related to their health and the increasing aging population with chronic diseases. Also, technological developments to boost the connected wearable patch with more data accuracy and features are anticipated to bring new advanced opportunities for the market in the coming future.

Based on the application, the clinical segment shares the highest market during the estimated period. It helps to gather information on a regular basis and then transforms data to connected devices such as laptops and smartphones so that the physicians have access to a real-time, continuous flow of data, which can avert patient worsening.

North America held the highest revenue share of 36.0% in 2024 due to its rising aging population, technological improvement in electronic skin, and increasing investment in R&D. In addition, increasing collaborations between hospitals, academic institutions, and widespread R&D activities at the industrial and academic level and increase in the scope of biomedical applications, have fueled the market growth. Moreover, the presence of major players in the region contributed to market growth.

Request sample report of Wearable Patch Market@ https://www.grandviewresearch.com/industry-analysis/wearable-patch-market/request/rs1

A wearable patch, also known as an electronic skin or smart patch, is used for disease monitoring, diagnostics, and drug delivery. It mainly benefits elderly patients with chronic conditions such as diabetes. The market is projected to grow significantly due to increasing R&D investments in wearable patch development. Wearable patches, such as scopolamine and transdermal patches, are directly attached to the affected body parts for disease monitoring. For example, a nicotine patch is used in Nicotine Replacement Therapy (NRT), which releases nicotine into the body and helps prevent smoking.

The wearable patches market is experiencing significant growth, driven by advancements in healthcare technology and rising demand for remote patient monitoring. These patches, often equipped with sensors, track various health metrics such as glucose levels, heart rate, and body temperature, providing real-time data to healthcare providers. They are non-invasive, user-friendly, and enhance patient compliance. The market benefits from aging populations, and a shift towards personalized medicine, increasing prevalence of chronic diseases such as atrial fibrillation and diabetes, which are causing stroke incidents at a higher rate, which is expected to drive the market over the projected period. For instance, according to euronews data published in May 2024, a new arm patch allows non-diabetics to track their blood sugar levels in real time using their smartphones. This wearable patch provides continuous glucose monitoring, helping users maintain balanced energy levels and make informed dietary choices.

Likewise, the increasing prevalence of atrial fibrillation is a major factor driving the market. For instance, in September 2023, FDA-approved devices such as Wellysis's S-Patch Ex and SmartCardia's 7L patch have advanced features that enhance real-time cardiac monitoring. These devices are designed to give doctors a detailed view of patients' cardiac activity over several days, aiding in detecting atrial fibrillation, arrhythmias, and other heart conditions. As these devices offer comprehensive and continuous health data, they meet the rising demand for effective, non-invasive monitoring solutions, thus contributing to market expansion.

According to two American Heart Association presidential advisories published in June 2024, heart disease and stroke may affect at least 60% of U.S. adults by 2050. Researchers also predict that by 2050, the prevalence of cardiovascular disease will rise to 15% of the population, up from 11.3% in 2020, excluding individuals with high blood pressure. This includes a projected doubling of stroke rates. The expressions that support our sayings are,

"The last decade has seen a surge of cardiovascular risk factors such as uncontrolled high blood pressure, diabetes and obesity, each of which raises the risks of developing heart disease and stroke, it is not surprising that an enormous increase in cardiovascular risk factors and diseases will produce a substantial economic burden. The last of the Baby Boomers will hit 65 in 2030, so about 1 in 5 people in the U.S. will be over 65, outnumbering children for the first time in U.S. history. Since cardiovascular risk increases with age, the aging population increases the total burden of cardiovascular disease in the country. By 2060, more than two-thirds of children will belong to underserved, disenfranchised populations, which traditionally have higher rates of cardiovascular disease and risk factors,"

- Dr. Dhruv S. Kazi, vice chair of the advisory writing group

Increasing technological advancement in wearable patches is also a major reason for the growth of the market. For instance, according to ScienceDaily data published in May 2024, researchers at the California University in San Diego have developed a wearable ultrasound patch for non-invasive, continuous monitoring of cerebral blood flow. This soft, stretchy patch can be worn on the temple and provides three-dimensional data on brain blood flow, overcoming limitations of traditional transcranial Doppler ultrasound. It offers hands-free, consistent monitoring, crucial for detecting fluctuations and potential strokes, especially during a patient’s hospital stay. This innovation, the first of its kind, enhances the ability to monitor and manage neurological conditions effectively.

In addition, the integration of artificial intelligence and data analytics in wearable patches improves diagnostic capabilities and personalized treatment plans, further driving market growth. For instance, in May 2023, researchers at Monash University have developed an AI-powered wearable patch that monitors multiple health signs, including speech, neck movement, touch, breathing, and heart rates. The ultra-thin patch, worn on the neck, uses a frequency/amplitude-based neural network to automatically track and analyze these biometrics, offering a comprehensive solution for remote health monitoring. The convergence of these factors creates a robust ecosystem for the expansion and innovation of wearable health technologies.